13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)

In addition, Advisors and GP III, pursuant to their authority under the limited partnership agreements of OPI III and/or Associates III, prior to the date of this filing, caused OPI III and Associates III, as applicable, to enter into the agreements referred to in Item 6 below.

 (c)

Seller	Date of Transaction	Transaction	Number of Shares	Price Per Share*
OPI III	December 18, 2017	Acquired upon the exercise of stock options	27,241	$2.00
Associates III	December 18, 2017	Acquired upon the exercise of stock options	259	$2.00
OPI III	December 18, 2017	Acquired upon the exercise of stock options	5,227	$3.00
Associates III	December 18, 2017	Acquired upon the exercise of stock options	50	$3.00
OPI III	December 18, 2017	Acquired upon the exercise of stock options	6,654	$2.62
Associates III	December 18, 2017	Acquired upon the exercise of stock options	63	$2.62
OPI III	December 18, 2017	Acquired upon the exercise of stock options	8,717	$1.94
Associates III	December 18, 2017	Acquired upon the exercise of stock options	83	$1.94
OPI III	December 18, 2017	Acquired upon the exercise of stock options	10,180	$1.62
Associates III	December 18, 2017	Acquired upon the exercise of stock options	97	$1.62
OPI III	December 18, 2017	Acquired upon the exercise of stock options	19,811	$1.59
Associates III	December 18, 2017	Acquired upon the exercise of stock options	189	$1.59
OPI III	December 18, 2017	Acquired upon the exercise of stock options	8,097	$2.05
Associates III	December 18, 2017	Acquired upon the exercise of stock options	77	$2.05
OPI III	December 18, 2017	Acquired upon the exercise of stock options	9,642	$1.73
Associates III	December 18, 2017	Acquired upon the exercise of stock options	92	$1.73
OPI III	December 18, 2017	Acquired upon the exercise of stock options	10,182	$1.64
Associates III	December 18, 2017	Acquired upon the exercise of stock options	97	$1.64
OPI III	December 18, 2017	Acquired upon the exercise of stock options	14,858	$2.01
Associates III	December 18, 2017	Acquired upon the exercise of stock options	142	$2.01
OPI III	December 18, 2017	Acquired upon the exercise of stock options	10,216	$2.01
Associates III	December 18, 2017	Acquired upon the exercise of stock options	97	$2.01
OPI III	December 18, 2017	Acquired upon the exercise of stock options	10,447	$2.32
Associates III	December 18, 2017	Acquired upon the exercise of stock options	99	$2.32
OPI III	December 18, 2017	Acquired upon the exercise of stock options	4,971	$5.64
Associates III	December 18, 2017	Acquired upon the exercise of stock options	47	$5.64
OPI III	December 18, 2017	Sold	146,243	$5.70
Associates III	December 18, 2017	Sold	1,392	$5.70
OPI III	January 3, 2018	Sold	1,693,492	$7.35
Associates III	January 3, 2018	Sold	16,128	$7.35

* The Shares were sold in a block order at a price of $5.70 (December 18, 2017) and $7.35 (January 3, 2018).